Search research articles
Contact Us
Filters
Showing results (791-800 of 1,192) with videos related to
Page
of 120
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 17, 2023
Efficacy and Safety of the TYK2/JAK1 Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase IIb Randomized Controlled Trial
Philip Mease, Philip Helliwell, Paula Silwinska-Stanczyk, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
November 11, 2011
A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans
Gerardo Colon-Otero, Monica Albertie, Mary Lesperance, et al.
Cancer
|
January 9, 2020
Venous thromboembolism risk with contemporary lenalidomide-based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta-analysis
Rajshekhar Chakraborty, Irbaz Bin Riaz, Saad Ullah Malik, et al.
Chemical Science
|
March 24, 2018
Teixobactin analogues reveal enduracididine to be non-essential for highly potent antibacterial activity and lipid II binding
Anish Parmar, Abhishek Iyer, Stephen H Prior, et al.
Blood
|
October 19, 2007
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
Angela Dispenzieri, Robert A Kyle, Jerry A Katzmann, et al.
Blood
|
August 24, 2011
Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone
Shaji K Kumar, Hajime Uno, Susanna J Jacobus, et al.
Blood
|
March 17, 2012
Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma
Shaji Kumar, Ian Flinn, Paul G Richardson, et al.
Cancer Research
|
February 7, 2002
Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study
Rafael Fonseca, David Harrington, Martin M Oken, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
January 23, 2025
Textbook Outcomes Among Patients Undergoing CRS+HIPEC for Peritoneal Surface Malignancies in an Eastern European Population
Sebastian Kobiałka, Marcin Kubiak, Katarzyna Sędłak, et al.
Haematologica
|
June 5, 2013
A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?
Nelson Leung, Siobhan V Glavey, Shaji Kumar, et al.
Page
of 120
Search research articles
Search
Showing results (791-800 of 1,192) with videos related to
Sort By:
Page
of 120
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 17, 2023
Efficacy and Safety of the TYK2/JAK1 Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase IIb Randomized Controlled Trial
Philip Mease, Philip Helliwell, Paula Silwinska-Stanczyk, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
November 11, 2011
A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans
Gerardo Colon-Otero, Monica Albertie, Mary Lesperance, et al.
Cancer
|
January 9, 2020
Venous thromboembolism risk with contemporary lenalidomide-based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta-analysis
Rajshekhar Chakraborty, Irbaz Bin Riaz, Saad Ullah Malik, et al.
Chemical Science
|
March 24, 2018
Teixobactin analogues reveal enduracididine to be non-essential for highly potent antibacterial activity and lipid II binding
Anish Parmar, Abhishek Iyer, Stephen H Prior, et al.
Blood
|
October 19, 2007
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
Angela Dispenzieri, Robert A Kyle, Jerry A Katzmann, et al.
Blood
|
August 24, 2011
Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone
Shaji K Kumar, Hajime Uno, Susanna J Jacobus, et al.
Blood
|
March 17, 2012
Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma
Shaji Kumar, Ian Flinn, Paul G Richardson, et al.
Cancer Research
|
February 7, 2002
Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study
Rafael Fonseca, David Harrington, Martin M Oken, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
January 23, 2025
Textbook Outcomes Among Patients Undergoing CRS+HIPEC for Peritoneal Surface Malignancies in an Eastern European Population
Sebastian Kobiałka, Marcin Kubiak, Katarzyna Sędłak, et al.
Haematologica
|
June 5, 2013
A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?
Nelson Leung, Siobhan V Glavey, Shaji Kumar, et al.
Page
of 120